Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 20, 2022

SELL
$64.88 - $73.64 $389,280 - $441,840
-6,000 Closed
0 $0
Q2 2020

Jul 15, 2020

BUY
$72.34 - $84.0 $434,040 - $504,000
6,000 New
6,000 $462,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $116B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Chapman Investment Management, LLC Portfolio

Follow Chapman Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chapman Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chapman Investment Management, LLC with notifications on news.